Federal Trade Commission, Plaintiff, v. Watson Pharmaceuticals, Inc., a corporation; Par Pharmaceutical Companies, Inc., a corporation; Paddock Laboratories, Inc., a corporation; and Solvay Pharmaceuticals, Inc., a corporation, Defendants
(Supreme Court of the United States)
(Appeal from Circuit Court of Appeals for the Eleventh Circuit)
(Appeal from United States District Court for the Northern District of Georgia)
(Transferred from United States District Court for the Central District of California)

[View United States District Court for the Central District of California Case Page]
Supreme Court Case No. 12-416
11th Cir. Case No. 10-12729-DD
N.D.Ga. Civil No. 1:09-CV-00955-TWT
C.D.Ca. Civil No. CV-09-00598
FTC File No. 071 0060

March 22, 2013

• Order by the U.S. Supreme Court Granting Motion of the Solicitor General to Unseal Volume 2 of the Joint Appendix [PDF – 1 page]

March 21, 2013

• Opinion and Order by the U.S. Court of Appeals for the Eleventh Circuit Affirming the District Court Ruling and Vacating the Stay Entered by the Court [PDF – 33 pages]

March 18, 2013

• Reply Brief for the Petitioner

January 22, 2013

• Brief for the Petitioner Federal Trade Commission [PDF - 131 pages]
• Joint Appendix (Volume 1) [PDF – 105 pages]
• Joint Appendix (Volume 2) [Seal Lifted] [PDF – 16 pages]

November 21, 2012

• Reply Brief for the Petitioner Federal Trade Commission [PDF - 13 pages]

October 4, 2012

• Petition for a Writ of Certiorari by the Federal Trade Commission Before the Supreme Court of the United States
• News Release

December 15, 2010

• Reply Brief for Plaintiff-Appellant Federal Trade Commission

July 26, 2010

• Appeal Brief by Plaintiff-Appellant Federal Trade Commission

June 10, 2010

• Notice of Appeal

April 16, 2010

• Federal Trade Commission’s Motion for Entry of Judgment

September 11, 2009

• Reply Memorandum of Law in Support of Defendants? Par Pharmaceutical Companies, Inc. and Paddock Laboratories, Inc., Motion to Dismiss the Second Amended Compliant
• Reply Memorandum in Support of Defendants? Motion to Dismiss the Second Amended Complaint

August 21, 2009

• Federal Trade Commission’s Consolidated Opposition to Defendants’ Motions to Dismiss

August 8, 2009

• Plaintiff Federal Trade Commission's Consolidated Opposition to Defendants' Motions to Dismiss

July 20, 2009

• Defendants Par Pharmaceutical Companies, Inc. and Paddock Laboratories, Inc., Motion to Dismiss the Second Amended Compliant
• Memorandum of Law in Support of Defendants? Motion to Dismiss the Second Amended Complaint
• Memorandum of Law in Support of Defendants Par Pharmaceuticals Companies, Inc. and Paddock Laboratories, Inc.?s Motion to Dismiss the Second Amended Complaint

May 28, 2009

• Second Amended Complaint For Injunctive and Other Equitable Relief (After Transfer of Venue From the United States District Court For the Central District of California to the United States District Court For the Northern District of Georgia, Atlanta Division)